Long-acting galenical formulation for grf peptides

Details Long-acting galenical formulation for grf peptides Long-acting galenical formulation for grf peptides

A - Human Necessities

61

K

A61K 38/25 (2006.01) A61K 9/00 (2006.01) A61K 9/20 (2006.01)

Patent

CA 2257837

The present invention relates to a long-acting galenical formulation of GRF peptides, pro-GRF and/or analogs thereof which comprises about 1 to about 100 mg of a GRF peptide, fragment or analog thereof pressed from about 1 to about 100 kg/mm2 in a tablet for parenteral administration, whereby these GRF peptides are released as the tablet is eroded.

La présente invention concerne une formulation galénique retard de peptides GRF, pro-GRF et/ou d'analogues de ceux-ci, formulation comprenant environ 1 à environ 100 mg d'un peptide GRF, d'un fragment ou d'un analogue de celui-ci compressé entre environ 1 et environ 100 kg/mm?2¿ sous forme d'un comprimé destiné à être administré par voie parentérale. Ces peptides GRF se libèrent lorsque le comprimé est érodé.

Affiliated with

Also associated with

Rating

Long-acting galenical formulation for grf peptides does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Long-acting galenical formulation for grf peptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Long-acting galenical formulation for grf peptides will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1490589